Publication Date

1-1-2020

Journal

Frontiers in Endocrinology

DOI

10.3389/fendo.2020.00350

PMID

32547497

PMCID

PMC7272571

PubMedCentral® Posted Date

5-29-2020

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes

Keywords

Adult, Autoimmune Hypophysitis, Crohn Disease, Female, Humans, Immunosuppressive Agents, Infliximab, Treatment Outcome, Tumor Necrosis Factor-alpha, pituitary, granulomatous hypophysitis, inflammatory bowel disease, Crohn's disease, anti-TNF-alpha, infliximab, adalimumab, case report

Abstract

Associated Data

Comments

Associated Data

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.